1-4 of 4
Robert C. Young
Close
Sort by
Journal Articles

A Prospective Trial of Radiation Alone vs Combination Chemotherapy Alone for Early-Stage Hodgkin’s Disease: Implications of 25-Year Follow-Up to Current Combined Modality Therapy.

Dan L. Longo, Eli Glatstein, Patricia L. Duffey, Robert C. Young, Shelby Fiem, Elaine S. Jaffe, Kevin Camphausen, Wyndham Wilson, Vincent T. DeVita
Journal: Blood
Blood (2006) 108 (11): 98.
https://doi.org/10.1182/blood.V108.11.98.98
Published: 2006
Journal Articles

Potential for Prolonged Disease-free Survival Following Combination Chemotherapy of Non-Hodgkin’s Lymphoma

Philip S. Schein, M.D., M.R.C.P., Bruce A. Chabner, M.D., F.A.C.P., George P. Canellos, M.D., F.A.C.P., Robert C. Young, M.D., F.A.C.P., Costan Berard, M.D., Vincent T. DeVita, M.D., F.A.C.P.
Journal: Blood
Blood (1974) 43 (2): 181–189.
https://doi.org/10.1182/blood.V43.2.181.181
Published: 1974
Journal Articles

Hodgkin’s Disease in Childhood

Robert C. Young, M.D., F.A.C.P., Vincent T. DeVita, M.D., F.A.C.P., Ralph E. Johnson, M.D.
Journal: Blood
Blood (1973) 42 (2): 163–174.
https://doi.org/10.1182/blood.V42.2.163.163
Published: 1973
Journal Articles

Phytohemagglutinin-induced Lymphocyte Transformation: The Relationship to Prognosis of Hodgkin’s Disease

Michael P. Corder, M.D., Robert C. Young, M.D., Robert S. Brown, M.D., Vincent T. DeVita, M.D.
Journal: Blood
Blood (1972) 39 (5): 595–601.
https://doi.org/10.1182/blood.V39.5.595.595
Published: 1972